Home » Tenders » Americas » USA » Yellow Fever Vaccine Tender, USA - 98925313

Yellow Fever Vaccine Tender, USA - 98925313

DEPT OF DEFENSE has floated a tender for Yellow Fever Vaccine. The project location is USA and the tender is closing on 18 Mar 2024. The tender notice number is SPE2DP24Q0084, while the TOT Ref Number is 98925313. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : USA

Summary : Yellow Fever Vaccine

Deadline : 18 Mar 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98925313

Document Ref. No. : SPE2DP24Q0084

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Tender Details

Description

The Defense Logistics Agency- Troop Support is seeking sources capable of providing YELLOW FEVER VACCINE, USP, One Vial (Sufficient for 5 Doses). CONTAINS 3ML. UNIT OF ISSUE: "EACH" (1 VIAL). REQ REFRIG. BTWN 2-8 DEG. C; SUBJECT TO DAMAGE BY FREEZING. Shelf life is 12 months. At least 10 months of shelf life shall remain at the time of delivery to the first government activity.

DLA Troop Support has a requirement for Yellow Fever Vaccine of 47 Vials. The vaccine shall be delivered to the Defense Distribution Depot Norfolk, VA, and the desirable delivery time is end of March 2024.

This is a request for information (RFI) and does not commit the U.S. Government to issue a solicitation, make an award, or pay any costs associated with responding to the RFI. All submitted information shall remain with the U.S. Government and will not be returned.

*** Currently Marketed YELLOW FEVER VACCINE***

If your firm currently markets YELLOW FEVER VACCINE, please provide information with respects to the following:

1.Place of Manufacture

2.FDA registration information

3.Product Name and description including description of any special features

4.Current unit sale price

5.Delivery days for this item and earliest product available time

*** New Products Under Development ***

For products under development, describe the current stage of development and whether the product has undergone independent laboratory testing or FDA testing/trials etc. Firms and organizations that currently develop or manufacture product described in this RFI or that have technologies, pharmaceuticals, or manufacturing capabilities under development are invited to submit information to DLA Troop Support.

Data obtained from this Request For Information (RFI) will be used by DLA Troop Support in making recommendations and decisions on the development of an appropriate planning and procurement strategy for Yellow Fever Vaccine. All information submitted w...
Active Contract Opportunity Notice ID SPE2DP24Q0084 Related Notice Department/Ind. Agency DEPT OF DEFENSE Sub-tier DEFENSE LOGISTICS AGENCY Major Command TROOP SUPPORT MEDICAL Office DLA TROOP SUPPORT
General Information
Contract Opportunity Type: Sources Sought (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Mar 14, 2024 03:58 pm EDT
Original Response Date: Mar 18, 2024 05:00 am EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Apr 02, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing

Place of Performance: USA